Brokerages Set Aurora Cannabis Inc. (TSE:ACB) Price Target at C$5.85

Shares of Aurora Cannabis Inc. (TSE:ACB) have received a consensus recommendation of “Moderate Buy” from the five ratings firms that are presently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and two have assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is C$7.11.

ACB has been the subject of several research analyst reports. ATB Capital reduced their target price on Aurora Cannabis from C$11.00 to C$8.50 in a research note on Tuesday, December 17th. Atb Cap Markets upgraded Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th. Finally, TD Securities raised Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th.

Aurora Cannabis Stock Performance

Shares of ACB opened at C$9.50 on Friday. Aurora Cannabis has a 12 month low of C$3.84 and a 12 month high of C$12.85. The stock has a fifty day moving average price of C$6.18 and a 200-day moving average price of C$7.18. The company has a current ratio of 3.76, a quick ratio of 2.48 and a debt-to-equity ratio of 16.95. The firm has a market cap of C$519.27 million, a PE ratio of -15.08 and a beta of 2.71.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.